Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

Some interesting remarks re the AF hit piece today:

@TheMach99
Replying to
@AdamSinger
$auph 036 patent is stronger than the NVS Gilenya dosing patent. Sun will need to provide clinical safety and efficacy in LN. This unlikely to get past the petition phase.

Replying to
@adamfeuerstein
I think I was the first one on the scene reporting the patent challenge. I am not sure how much the news challenges the $AUPH takeout hopes. The Markman Hearing / Opinion to be held in the next 2 months and issued shortly after is the next key milestone.
biostockGuru
@biostockguru

Replying to
@sentivcapital
Some important information here is that $AUPH was suing Sun Pharma first. It's fairly common for parties to counterattack the other by trying to invalidate their patents. This is intended to put pressure on $AUPH, but it doesn't mean Sun has a case.